Home -> Law Blog Directory -> Personal Injury Law Blogs -> San Diego Injury Lawyer Blog
(866) 635-2689 for Personal Injury or (866) 635-9402 for Criminal Defense
Find a Local Lawyer
Divorce (866) 635-6190
Personal Injury (866) 635-2689
Criminal Defense (866) 635-9402
Personal Injury Law
: San Diego Injury Lawyer BlogFDA Issues Warning to San Diego About the Psoriasis Drug, Raptiva
By Ross Jurewitz
The Food and Drug Administration has issued a warning to San Diego doctors specializing in dermatology and patients about the psoriasis drug efalizumab, or Raptiva. This warning is linked to three deaths and possibly a fourth.
The three that were confirmed dead were all taking the drug Raptiva and were reported to have had a rare brain infection called progressive multifocal leukoencephalopathy (PML). In October of 2008, the FDA forced the drug maker, Genentech to highlight in a warning regarding the risks of life-threatening infections, including PML, on their product packaging.
The FDA has also directed Genentech to develop a Risk Evaluation and Mitigation Strategy to ensure that patients receive risk information about Raptiva. Also, the FDA wants to make sure that the risks do not outweigh the benefits.
Full post as published by San Diego Injury Lawyer Blog on February 27, 2009 (boomark / email).
Mitchell Report Summary
Report on Steroid Drug Use in Major League Baseball by Senator George Mitchell
FDA Issues Warning Regarding Topical Ibuprofen Drug Products
Topical Ibuprofen Drug Products FDA Issues Warning Letters
FDA Issues Safety Warning About Valproic Acid and Divalproex Sodium
Valproic Acid and Divalproex Sodium FDA Issues Safety Warning About Risk for Birth Defects
FDA Issues Warning about Promethazine Hydrochloride Injection
Promethazine Hydrochloride Injection FDA issues warning
Venom HYPERDRIVE 3.0
FDA Issues Warning
Lead-Contaminated Meat
N. Dakota Issues Warning
Health Canada Issues Warning
for Antibiotic Rofact (Rifampin)

FDA Warns Of Deaths Due To Raptiva
Raptiva: An Itch That Can Kill
FDA Announces Label Change For Raptiva
Raptiva PML Deaths Under FDA Review: Safety of Genentech's Psoriasis Drug Questioned









